Kandasamy Kumar E

Non-alcoholic Fatty Liver Disease Assessed by FIBROSCAN-AST (FAST) Score and Its Association with Colorectal Carcinoma Risk: A Case-Control Study

Jishnu J, Kandasamy Kumar E, Poppy Rejoice, Shafique A & Geetha D · Asian Journal of Research and Reports in Hepatology · 2024

Background: Non-alcoholic fatty liver disease (NAFLD) is an entity with its evident role in systemic inflammation and tumorigenesis. Notably, the association between colorectal cancer (CRC) and NAFLD identified by the FibroScan-AST (FAST) score allows the assessment of steatosis...

Open access Research Article 10.9734/ajrrhe/2024/v6i143

Prevalence and Risk Factors for Metabolic-dysfunction Associated Fatty Liver Disease in South Indian Population

Dhivya E, Kandasamy Kumar E, Poppy Rejoice, Shafique A & Geetha D · International Research Journal of Gastroenterology and Hepatology · 2024

Background: Metabolic associated fatty liver disease (MAFLD) is a new definition proposed by the global consensus panel in 2020 for liver disease associated with known metabolic dysfunction. Based on new diagnostic criteria, we aimed to investigate its prevalence and risk factors...

Open access Research Article 10.9734/irjgh/2024/v7i1106